NEW YORK--(BUSINESS WIRE)--SIGA Technologies, Inc. (NASDAQ: SIGA) announced that, on November 16, 2006, its Chief Scientific Officer, Dr. Dennis E. Hruby, will make a presentation on the progress of SIGA-246 to the World Health Organization’s Smallpox Advisory Committee on Variola Virus Research. Dr. Hruby is attending by invitation and will serve as a temporary advisor to the Committee which is meeting in Geneva, Switzerland. This is the second year in a row that Dr. Hruby has been invited to make a presentation to the WHO on the development status of SIGA’s smallpox antiviral drug (SIGA-246). “Given the central role of the WHO in safeguarding the health and well-being of the global citizenry, we appreciate the opportunity to update them on the recent significant advancements in developing SIGA-246 since we introduced the compound to the WHO last year,” commented Dr. Hruby.
